ClinicalTrials.Veeva

Menu

Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event

T

Tiohundra

Status

Unknown

Conditions

Ischemic Attack, Transient

Treatments

Other: Physical activation on Prescription

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01509924
Tiohundra

Details and patient eligibility

About

The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active.

One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care.

And to identify if persons with TIA presents with cognitive impairments.

Full description

Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Understand Swedish language (also in and writing), living in Norrtälje community,
  • To participate in the assessment of cognitive function: no known cognitive impairments before the TIA event and history of stroke.

Exclusion criteria

  • Presence of contraindications to exercise, and no history of stroke

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 4 patient groups

Physical activity on Prescription (PaP)
Experimental group
Description:
Intervention group receives a PaP for 12 month.
Treatment:
Other: Physical activation on Prescription
Control Group
No Intervention group
Description:
The control group has the same monitoring as the experimental group but receives no PaP.
Cognitiv function in patients with TIA
No Intervention group
Description:
Before discharged from hospital cognitive function is assessed. At the first visit the patients fill in a self assessment questionnaire for mental fatigue. If impaired at the previous assessment cognitive function will be assessed at 3, 6 and 12 month.
Controlgroup Cognitive function
No Intervention group
Description:
In order to determine whether hospitalization in itself is associated with transient impaired cognition, a comparison group will be included. The comparison group will consist of patients with angina pectoris consecutively admitted to the Norrtälje Hospital. The patients with angina pectoris will be age and sex matched with the patients with TIA and assessed for cognitive function when their angina symptoms have subsided.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems